Related Experiment Videos
Phase II study of bleomycin, dacarbazine (DTIC) and vindesine in disseminated malignant melanoma
N H Mulder1, D T Sleijfer, E G de Vries
1Department of Internal Medicine, University Hospital Groningen, The Netherlands.
Journal of Cancer Research and Clinical Oncology
|January 1, 1989
Abstract:
Thirty-one patients with disseminated malignant melanoma were treated with a combination chemotherapy of bleomycin, dacarbazine and vindesine. Five complete responses, and five partial remissions occurred. One patient survived for over 2 years without evidence of disease. This combination of drugs may give better results, as far as complete recovery and long-term survival are concerned, than single-agent therapy with dacarbazine.